Gen-Probe Reports Positive Regulatory Progress For PROCLEIX(R) ULTRIO(R) Blood Screening Assay On The TIGRIS(R) System

Tue, 30 Jan 2007 02:00 PM EST

... Gen-Probe (Nasdaq: GPRO) announced today that the Company has submitted to the U.S. Food and Drug Administration (FDA) a regulatory application to run the PROCLEIX(R) ULTRIO(R) blood screening assay on the fully automated TIGRIS(R) system, and that a post-marketing study of the assay to detect Hepatitis B yield is expected to begin in March. [click link for full article] ...